Association of Research and Development Investments With Treatment Costs for New Drugs Approved From 2009 to 2018.

Wouters, Olivier J; Berenbrok, Lucas A; He, Meiqi; Li, Yihan; Hernandez, Inmaculada

Wouters, Olivier J; Berenbrok, Lucas A; He, Meiqi; Li, Yihan; Hernandez, Inmaculada.

Afiliación

Wouters OJ; Department of Health Policy, London School of Economics and Political Science, London, United Kingdom.
Berenbrok LA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.
He M; Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla.
Li Y; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.
Hernandez I; Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla.

JAMA Netw Open ; 5(9): e2218623, 2022 09 01.

Article en En | MEDLINE | ID: mdl-36156148

Asunto(s)

Costos de los Medicamentos; Industria Farmacéutica; Costos y Análisis de Costo; Estudios Transversales; Humanos; Investigación

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Costos de los Medicamentos / Industria Farmacéutica Tipo de estudio: Health_economic_evaluation / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JAMA Netw Open Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google